Skip to main content
. 2022 Nov 2;13:971065. doi: 10.3389/fphar.2022.971065

FIGURE 4.

FIGURE 4

Summary of in vitro validation models. Listed in vitro models arranged from the assay containing the most tissue complexity down to single cells, listing the pros and cons for the different models. The physiological complexity of the different models impacts both the screening capacity of the assay and what biology that translates. MPS, micro-physiological systems. aconsiderations are listed in a step-wise manner and main considerations only are stated.